135 related articles for article (PubMed ID: 18449889)
21. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
[TBL] [Abstract][Full Text] [Related]
22. Cause-specific telomere factors deregulation in hepatocellular carcinoma.
El Idrissi M; Hervieu V; Merle P; Mortreux F; Wattel E
J Exp Clin Cancer Res; 2013 Sep; 32(1):64. PubMed ID: 24020493
[TBL] [Abstract][Full Text] [Related]
23. Noncoding telomeric repeat-containing RNA inhibits the progression of hepatocellular carcinoma by regulating telomerase-mediated telomere length.
Cao H; Zhai Y; Ji X; Wang Y; Zhao J; Xing J; An J; Ren T
Cancer Sci; 2020 Aug; 111(8):2789-2802. PubMed ID: 32357278
[TBL] [Abstract][Full Text] [Related]
24. Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis.
Park YM; Choi JY; Byun BH; Cho CH; Kim HS; Kim BS
Exp Mol Med; 1998 Mar; 30(1):35-40. PubMed ID: 9873820
[TBL] [Abstract][Full Text] [Related]
25. Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.
Donaires FS; Scatena NF; Alves-Paiva RM; Podlevsky JD; Logeswaran D; Santana BA; Teixeira AC; Chen JJ; Calado RT; Martinelli ALC
PLoS One; 2017; 12(8):e0183287. PubMed ID: 28813500
[TBL] [Abstract][Full Text] [Related]
26. POT1 as a terminal transducer of TRF1 telomere length control.
Loayza D; De Lange T
Nature; 2003 Jun; 423(6943):1013-8. PubMed ID: 12768206
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B.
Jung SW; Park NH; Shin JW; Park BR; Kim CJ; Lee JE; Shin ES; Kim JA; Chung YH
Hepatology; 2014 May; 59(5):1912-20. PubMed ID: 23907815
[TBL] [Abstract][Full Text] [Related]
28. Frequent changes in subtelomeric DNA methylation patterns and its relevance to telomere regulation during human hepatocarcinogenesis.
Oh BK; Um TH; Choi GH; Park YN
Int J Cancer; 2011 Feb; 128(4):857-68. PubMed ID: 20473888
[TBL] [Abstract][Full Text] [Related]
29. A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes.
Escoffier E; Rezza A; Roborel de Climens A; Belleville A; Gazzolo L; Gilson E; Duc Dodon M
Retrovirology; 2005 Dec; 2():77. PubMed ID: 16354306
[TBL] [Abstract][Full Text] [Related]
30. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method.
Iizuka N; Oka M; Yamada-Okabe H; Mori N; Tamesa T; Okada T; Takemoto N; Tangoku A; Hamada K; Nakayama H; Miyamoto T; Uchimura S; Hamamoto Y
Cancer Res; 2002 Jul; 62(14):3939-44. PubMed ID: 12124323
[TBL] [Abstract][Full Text] [Related]
31. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease.
Kojima H; Yokosuka O; Imazeki F; Saisho H; Omata M
Gastroenterology; 1997 Feb; 112(2):493-500. PubMed ID: 9024303
[TBL] [Abstract][Full Text] [Related]
32. Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma.
Miura N; Shiota G; Nakagawa T; Maeda Y; Sano A; Marumoto A; Kishimoto Y; Murawaki Y; Hasegawa J
Oncology; 2003; 64(4):430-4. PubMed ID: 12759542
[TBL] [Abstract][Full Text] [Related]
33. [Correlation of telomere length and the expression of its regulating proteins in mesenchymal sarcomas].
Chi YK; Shen Q; Wang JC; Zheng XZ; Hou L; Zhang B
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):363-8. PubMed ID: 18677381
[TBL] [Abstract][Full Text] [Related]
34. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma.
Su PF; Lee TC; Lin PJ; Lee PH; Jeng YM; Chen CH; Liang JD; Chiou LL; Huang GT; Lee HS
Int J Cancer; 2007 Sep; 121(6):1257-64. PubMed ID: 17534893
[TBL] [Abstract][Full Text] [Related]
35. Chromosomal instability, telomere shortening, and inactivation of p21(WAF1/CIP1) in dysplastic nodules of hepatitis B virus-associated multistep hepatocarcinogenesis.
Lee YH; Oh BK; Yoo JE; Yoon SM; Choi J; Kim KS; Park YN
Mod Pathol; 2009 Aug; 22(8):1121-31. PubMed ID: 19465904
[TBL] [Abstract][Full Text] [Related]
36. Telomere length variation and maintenance in hepatocarcinogenesis.
Yokota T; Suda T; Igarashi M; Kuroiwa T; Waguri N; Kawai H; Mita Y; Aoyagi Y
Cancer; 2003 Jul; 98(1):110-8. PubMed ID: 12833463
[TBL] [Abstract][Full Text] [Related]
37. Gene expression of telomerase related proteins in human normal oral and ectocervical epithelial cells.
Fujimoto R; Kamata N; Taki M; Yokoyama K; Tomonari M; Nagayama M; Yasumoto S
Oral Oncol; 2003 Jul; 39(5):445-52. PubMed ID: 12747968
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms.
Brechot C; Kremsdorf D; Soussan P; Pineau P; Dejean A; Paterlini-Brechot P; Tiollais P
Pathol Biol (Paris); 2010 Aug; 58(4):278-87. PubMed ID: 20667665
[TBL] [Abstract][Full Text] [Related]
39. Perinodular ductular reaction/epithelial cell adhesion molecule loss in small hepatic nodules.
Zhang Q; Zhang CS; Xin Q; Ma Z; Liu GQ; Liu BB; Wang FM; Gao YT; Du Z
World J Gastroenterol; 2014 Aug; 20(31):10908-15. PubMed ID: 25152593
[TBL] [Abstract][Full Text] [Related]
40. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
Tharayil VS; Roberts LR
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
